iThera Medical is part of a consortium to develop a novel imaging platform for regenerative medicine. The project is led by Professor Martin Leahy from NUI Galway.
Molecular imaging of cancer biomarkers using multispectral optoacoustic tomography (MSOT)
Lacey McNally, PhD, Associate Professor, University of Louisville School of Medicine;
Clinton Hupple, MSc, Application Specialist, iThera Medical
University Hospital Erlangen publishes using MSOT: Multispectral Optoacoustic Tomography for Assessment of Crohn’s Disease Activity (New England Journal of Medicine)
Dr. Joachim Klode from the University Hospital Essen wins the “Deutscher Hautkrebspreis 2016” (German Skin Cancer Award) for his groundbreaking work on sentinel node detection and nodal assessment in melanoma patients using MSOT
Multispectral Optoacoustic Tomography (MSOT) enters the clinic
Joachim Klode MD, Associate Professor, Dermatologist, University Hospital Essen;
Neal C. Burton PhD, Senior Application Specialist, iThera Medica
MSOT on TV: The late night news on RTL covers MSOT as a novel technology to non-invasively detect lymph node metastastes in melanoma patients.
MSOT on TV: The science show X:enius on ARTE covers MSOT as a novel ultrasound-related imaging technology.
University Hospital Essen publishes using MSOT: Assessing the metastatic status of sentinel lymph nodes in melanoma patients (Science Translational Medicine)
University of Leeds publishes using MSOT: “Gold nanotubes launch a three-pronged attack on cancer cells”
MSOT for Imaging Biodistribution and Pharmacokinetics
Wouter Driessen, PhD, Probe Development Scientist, iThera Medical